Oral Hexadecyloxypropyl-Cidofovir Therapy in Pregnant Guinea Pigs Improves Outcome in the Congenital Model of Cytomegalovirus Infection

Comparative Efficacy of Treatment with CMX001 Versus Acyclovir in BALB/c Mice Infected with Herpes Simplex Virus

(2009) Debra Quenelle et al.   ANTIVIRAL RESEARCH

Alkoxyalkyl prodrugs of acyclic nucleoside phosphonates enhance oral antiviral activity and reduce toxicity: Current state of the art

(2009) Karl Y. Hostetler   ANTIVIRAL RESEARCH

Oral valganciclovir treatment in newborns with symptomatic congenital cytomegalovirus infection

(2009) G. Lombardi et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Treatment of congenital cytomegalovirus infection: implications for future therapeutic strategies

(2009) L. Nassetta et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system

(2009) Sara E. Oliver et al.   JOURNAL OF CLINICAL VIROLOGY

Vaccine Prevention of Maternal Cytomegalovirus Infection

(2009) Robert F. Pass et al.   NEW ENGLAND JOURNAL OF MEDICINE

Antivirals for Cytomegalovirus Infection in Neonates and Infants

(2009) Beth C. Marshall et al.   PEDIATRIC DRUGS

Pharmacokinetic and Pharmacodynamic Assessment of Oral Valganciclovir in the Treatment of Symptomatic Congenital Cytomegalovirus Disease

(2008) David W. Kimberlin et al.   JOURNAL OF INFECTIOUS DISEASES

Hexadecyloxypropyl-cidofovir, CMX001, prevents adenovirus-induced mortality in a permissive, immunosuppressed animal model

(2008) K. Toth et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Mousepox in the C57BL/6 strain provides an improved model for evaluating anti-poxvirus therapies

(2008) Scott Parker et al.   VIROLOGY